iRenix Medical Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

iRenix Medical General Information

Description

Developer of ophthalmic devices and drugs intended for targeting significant unmet needs within the eye care industry. The company specializes in combining ultrarapid cooling anesthesia with precision motor-driven injection, enabling healthcare providers to improve patients' intravitreal injection experience and allow retina specialists to meet the rapidly growing demand for intravitreal injections.

Contact Information

Website
www.irenix.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 350 Cambridge Avenue
  • Suite 300
  • Palo Alto, CA 94306
  • United States
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 350 Cambridge Avenue
  • Suite 300
  • Palo Alto, CA 94306
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iRenix Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-Jul-2026 Completed Generating Revenue
4. Seed Round 02-Jun-2023 Completed Startup
3. Grant 01-Jan-2020 Completed Startup
2. Grant 01-Jan-2018 $2.54M Completed Startup
1. Seed Round 26-Apr-2017 Completed Startup
To view iRenix Medical’s complete valuation and funding history, request access »

iRenix Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed II-B
Seed II-A
Seed II 937,545 $0.000100 $0.17 $2.13 $2.13 1x $2.13 9.32%
Seed 1,590,925 $0.000100 $0.01 $0.11 $0.11 1x $0.11 27.15%
To view iRenix Medical’s complete cap table history, request access »

iRenix Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iRenix Medical Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Heroic Ventures Venture Capital Minority
Michigan Biomedical Venture Fund Venture Capital Minority
Small Business Innovation Research and Small Business Technology Transfer Programs Government
University of Michigan Endowment Limited Partner Minority
To view iRenix Medical’s complete investors history, request access »

iRenix Medical FAQs

  • When was iRenix Medical founded?

    iRenix Medical was founded in 2016.

  • Where is iRenix Medical headquartered?

    iRenix Medical is headquartered in Palo Alto, CA.

  • What is the size of iRenix Medical?

    iRenix Medical has 5 total employees.

  • What industry is iRenix Medical in?

    iRenix Medical’s primary industry is Therapeutic Devices.

  • Is iRenix Medical a private or public company?

    iRenix Medical is a Private company.

  • What is iRenix Medical’s current revenue?

    The current revenue for iRenix Medical is .

  • How much funding has iRenix Medical raised over time?

    iRenix Medical has raised $2.5M.

  • Who are iRenix Medical’s investors?

    Heroic Ventures, Michigan Biomedical Venture Fund, Small Business Innovation Research and Small Business Technology Transfer Programs, and University of Michigan Endowment have invested in iRenix Medical.

  • When was iRenix Medical acquired?

    iRenix Medical was acquired on 08-Jul-2026.

  • Who acquired iRenix Medical?

    iRenix Medical was acquired by Tarsus Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process